News
The United States officially won't be involved in an enhanced pandemic global response enacted by the World Health ...
Following on from their breakthrough human trial that successfully reprogrammed the immune system to overpower glioblastoma, an aggressive brain tumor, the same scientists have now further developed ...
6h
Medpage Today on MSNInhaled Sedative Safe, Effective for Kids on Mechanical VentilationWhile midazolam is the only sedative labeled for continuous use during mechanical ventilation in pediatric ICU patients, ...
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
1h
The Brighterside of News on MSNNew universal cancer vaccine fights tumors by kickstarting immune defensesCancer immunotherapy has transformed the treatment landscape by helping the immune system recognize and attack tumors. At the ...
Tiny fat bubbles carrying gene therapy have successfully repaired DNA in the lungs and liver of animals with alpha-1 ...
What to know about COVID symptoms, testing and incubation as the new "razor blade throat" Nimbus variant has caused a summer 2025 spike.
The Trump administration says there won’t be a crackdown on pesticide use in the U.S. Politico says that’s despite a report from the Make America Healthy Again Committee that called crop protection ...
Borrowing from the anti-inflammatory properties of olive oil, Penn Engineers used a century-old chemical reaction to redesign ...
No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.
A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...
10h
News-Medical.Net on MSNOld chemistry unlocks safer and stronger mRNA deliveryAs millions of people know firsthand, the most common side effect of mRNA vaccines like the COVID-19 shot is inflammation: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results